Cargando…
Clinical characteristics and outcome of mucormycosis: A multi-center retrospective analysis in Saudi Arabia over 11 years
BACKGROUND: Mucormycosis is a life-threatening fungal infection with variable epidemiology between countries. Limited data are available locally; we aim to describe the clinical spectrum and outcome of mucormycosis in Saudi Arabia. METHODS: A retrospective multi-center study including all patients w...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356215/ https://www.ncbi.nlm.nih.gov/pubmed/35941863 http://dx.doi.org/10.1016/j.ijregi.2022.07.004 |
_version_ | 1784763467891212288 |
---|---|
author | Abanamy, Reem Alsaud, Abdulrahman Alabdulali, Rawan Alsobaie, Mohammed Alalwan, Bassam Aljohani, Sameera Alshieban, Saeed Turkistani, Hanan Almohaizeie, Abdullah Bosaeed, Mohammad AlRabiah, Fahad |
author_facet | Abanamy, Reem Alsaud, Abdulrahman Alabdulali, Rawan Alsobaie, Mohammed Alalwan, Bassam Aljohani, Sameera Alshieban, Saeed Turkistani, Hanan Almohaizeie, Abdullah Bosaeed, Mohammad AlRabiah, Fahad |
author_sort | Abanamy, Reem |
collection | PubMed |
description | BACKGROUND: Mucormycosis is a life-threatening fungal infection with variable epidemiology between countries. Limited data are available locally; we aim to describe the clinical spectrum and outcome of mucormycosis in Saudi Arabia. METHODS: A retrospective multi-center study including all patients with clinical and pathological evidence of mucormycosis in 3 tertiary care centers in Saudi Arabia from January 2009 to December 2019. RESULTS: Thirty-three patients were identified during the study period. The mean age was 42 years. People with diabetes accounted for 48% of the patient population. The most common site of infection was cutaneous (27%), followed by isolated sinusitis (21%) and pulmonary and rhino-orbital-cerebral mucormycosis (each 18%). The most common isolated species were Rhizopus (50%) and Mucor (15%). Most patients received medical therapy with amphotericin B (79%), and more than half were treated surgically. The 1-year mortality rate reached 48%, with higher mortality observed in disseminated and rhino-orbital-cerebral infections than in other sites. CONCLUSION: Our study addressed the epidemiology of mucormycosis in Saudi Arabia and showed comparable patterns of clinical and mycological aspects to worldwide reports. Further studies are needed to evaluate mucormycosis risk factors and prognosis based on the species, site of infection and therapy type. |
format | Online Article Text |
id | pubmed-9356215 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-93562152022-08-07 Clinical characteristics and outcome of mucormycosis: A multi-center retrospective analysis in Saudi Arabia over 11 years Abanamy, Reem Alsaud, Abdulrahman Alabdulali, Rawan Alsobaie, Mohammed Alalwan, Bassam Aljohani, Sameera Alshieban, Saeed Turkistani, Hanan Almohaizeie, Abdullah Bosaeed, Mohammad AlRabiah, Fahad IJID Reg Original Report BACKGROUND: Mucormycosis is a life-threatening fungal infection with variable epidemiology between countries. Limited data are available locally; we aim to describe the clinical spectrum and outcome of mucormycosis in Saudi Arabia. METHODS: A retrospective multi-center study including all patients with clinical and pathological evidence of mucormycosis in 3 tertiary care centers in Saudi Arabia from January 2009 to December 2019. RESULTS: Thirty-three patients were identified during the study period. The mean age was 42 years. People with diabetes accounted for 48% of the patient population. The most common site of infection was cutaneous (27%), followed by isolated sinusitis (21%) and pulmonary and rhino-orbital-cerebral mucormycosis (each 18%). The most common isolated species were Rhizopus (50%) and Mucor (15%). Most patients received medical therapy with amphotericin B (79%), and more than half were treated surgically. The 1-year mortality rate reached 48%, with higher mortality observed in disseminated and rhino-orbital-cerebral infections than in other sites. CONCLUSION: Our study addressed the epidemiology of mucormycosis in Saudi Arabia and showed comparable patterns of clinical and mycological aspects to worldwide reports. Further studies are needed to evaluate mucormycosis risk factors and prognosis based on the species, site of infection and therapy type. Elsevier 2022-07-08 /pmc/articles/PMC9356215/ /pubmed/35941863 http://dx.doi.org/10.1016/j.ijregi.2022.07.004 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Original Report Abanamy, Reem Alsaud, Abdulrahman Alabdulali, Rawan Alsobaie, Mohammed Alalwan, Bassam Aljohani, Sameera Alshieban, Saeed Turkistani, Hanan Almohaizeie, Abdullah Bosaeed, Mohammad AlRabiah, Fahad Clinical characteristics and outcome of mucormycosis: A multi-center retrospective analysis in Saudi Arabia over 11 years |
title | Clinical characteristics and outcome of mucormycosis: A multi-center retrospective analysis in Saudi Arabia over 11 years |
title_full | Clinical characteristics and outcome of mucormycosis: A multi-center retrospective analysis in Saudi Arabia over 11 years |
title_fullStr | Clinical characteristics and outcome of mucormycosis: A multi-center retrospective analysis in Saudi Arabia over 11 years |
title_full_unstemmed | Clinical characteristics and outcome of mucormycosis: A multi-center retrospective analysis in Saudi Arabia over 11 years |
title_short | Clinical characteristics and outcome of mucormycosis: A multi-center retrospective analysis in Saudi Arabia over 11 years |
title_sort | clinical characteristics and outcome of mucormycosis: a multi-center retrospective analysis in saudi arabia over 11 years |
topic | Original Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356215/ https://www.ncbi.nlm.nih.gov/pubmed/35941863 http://dx.doi.org/10.1016/j.ijregi.2022.07.004 |
work_keys_str_mv | AT abanamyreem clinicalcharacteristicsandoutcomeofmucormycosisamulticenterretrospectiveanalysisinsaudiarabiaover11years AT alsaudabdulrahman clinicalcharacteristicsandoutcomeofmucormycosisamulticenterretrospectiveanalysisinsaudiarabiaover11years AT alabdulalirawan clinicalcharacteristicsandoutcomeofmucormycosisamulticenterretrospectiveanalysisinsaudiarabiaover11years AT alsobaiemohammed clinicalcharacteristicsandoutcomeofmucormycosisamulticenterretrospectiveanalysisinsaudiarabiaover11years AT alalwanbassam clinicalcharacteristicsandoutcomeofmucormycosisamulticenterretrospectiveanalysisinsaudiarabiaover11years AT aljohanisameera clinicalcharacteristicsandoutcomeofmucormycosisamulticenterretrospectiveanalysisinsaudiarabiaover11years AT alshiebansaeed clinicalcharacteristicsandoutcomeofmucormycosisamulticenterretrospectiveanalysisinsaudiarabiaover11years AT turkistanihanan clinicalcharacteristicsandoutcomeofmucormycosisamulticenterretrospectiveanalysisinsaudiarabiaover11years AT almohaizeieabdullah clinicalcharacteristicsandoutcomeofmucormycosisamulticenterretrospectiveanalysisinsaudiarabiaover11years AT bosaeedmohammad clinicalcharacteristicsandoutcomeofmucormycosisamulticenterretrospectiveanalysisinsaudiarabiaover11years AT alrabiahfahad clinicalcharacteristicsandoutcomeofmucormycosisamulticenterretrospectiveanalysisinsaudiarabiaover11years |